title: Should coagulation tests be used to determine which oral contraceptive users have an increased risk of thrombophlebitis?
authors.affiliation: Hematology/Oncology Section, University of Oklahoma Health Sciences Center, Veterans Affairs Medical Center, Oklahoma City, 73104, USA. philip-comp@ouhsc.edu
authors.forename: Philip C
authors.initials: PC
authors.lastname: Comp
mesh_terms: D020016:Activated Protein C Resistance; D001780:Blood Coagulation Tests; D003276:Contraceptives, Oral / Q000009:adverse effects*; D005165:Factor V; D005260:Female; D006801:Humans; D009154:Mutation; D018455:Protein S Deficiency; D011516:Prothrombin / Q000032:analysis / Q000235:genetics; D012307:Risk Factors; D013924:Thrombophlebitis / Q000139:chemically induced* / Q000235:genetics
chemical_list: D003276:Contraceptives, Oral; C095381:factor V Leiden; D005165:Factor V; D011516:Prothrombin